Tag - alzheimers

 
Menu
Search
 
April 20, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

ALZHEIMERS

Alzheimer's drug lecanemab. A new trial is the world's first to combine lecanemab with a different drug.
JAPAN / Science & Health
Mar 15, 2024
Japan starts clinical trial of familial Alzheimer's treatment
The clinical trial is under way in 16 countries, with four people in their 30s to 50s participating in Japan.
Eisai's Alzheimer's drug Leqembi
BUSINESS / Companies
Feb 5, 2024
Eisai sees 'huge' growth potential for Alzheimer's drug in China
The Japanese pharmaceutical firm aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year.
Shitsui Hakoishi, 107, works with researcher Yasumichi Arai (left) while her younger brother, Hidemasa, looks on. Researchers like Arai believe the healthy and active Hakoishi's cells may hold the secret to living a long life.
JAPAN / Science & Health / Longform
Jan 27, 2024
Living until 100, if not forever, in good health
Immortality may be out of reach, but can a slew of research projects prolong our natural aging process?
The new Alzheimer's drug lecanemab, branded Leqembi
JAPAN
Dec 13, 2023
New Alzheimer's drug to be covered by health insurance in Japan
The drug, to be launched Dec. 20, will cost around ¥2.98 million per year in Japan but patients will only have to pay a limited share.
An elderly person plays a racing video game in 2022 to ward off dementia.
JAPAN / Science & Health
Sep 25, 2023
As Japan OKs Alzheimer's drug, issue of side effects comes into focus
There are big challenges ahead for the use of lecanemab, particularly on how to control side effects such as brain swelling and bleeding.
Shinobu Yamanaka, a mom of three sons and director of a day care facility in Konan, Kochi Prefecture, serves up to eight "members" six days a week.
JAPAN / Science & Health / FOCUS
Aug 22, 2023
Kochi dementia care center aims to set new paradigm in Japan
A new generation of people with Alzheimer’s in Japan are trying to change not only dementia care but also social attitudes toward patients.
Packages of lecanemab, marketed as Leqembi, for the U.S. market
JAPAN / Science & Health
Aug 21, 2023
Japanese ministry panel gives OK to Alzheimer’s drug lecanemab
The panel’s endorsement will be followed by official approval by the health minister in coming days.
Japan Times
WORLD / Science & Health
Jul 17, 2023
Alzheimer's diagnosis revamp embraces rating scale similar to cancer
New guidelines would replace terminology such as mild, moderate and severe, instead using a numerical system related to disease progression.
Japan Times
BUSINESS / Companies
Jul 11, 2023
Eisai appoints CEO’s son to lead global Alzheimer drug program
Eisai's former global Alzheimer drug program officer, who led the push for U.S. approval of breakthrough medicine Leqembi, will retire at the end of the month.
Japan Times
WORLD / Science & Health
Jul 7, 2023
Eisai Alzheimer's drug gets full U.S. approval, widening access to the therapy
The broader clearance from the Food and Drug Administration marks a milestone for treatment of the dementia that afflicts some 6 million Americans.
Japan Times
JAPAN / Science & Health / FOCUS
Jul 4, 2023
Expectations grow for Alzheimer's drug in Japan, but hurdles remain
Lecanemab could be approved in the country as early as fall, but more specialist doctors and a patient screening system would be needed for widespread use.
Japan Times
COMMENTARY / World
Jul 3, 2023
Can we cure dementia before it starts?
Octogenarian and biologist Leroy Hood is trying to make the Elizabeth Holmes-ian dream of preventive medicine come true.
Japan Times
WORLD / Science & Health
Jun 19, 2023
New Eisai and Biogen Alzheimer drug faces hurdles in Europe
Some doctors said its effect on the disease may not be clinically meaningful enough when weighed against the risk of brain swelling, its likely high price.
Japan Times
BUSINESS
Jun 1, 2023
Obesity and Alzheimer's news makes Eli Lilly world’s most valuable drugmaker
An 8.5% gain in May for Eli Lilly lifted its shares to a record high, while displaced Johnson & Johnson slumped 5.3% during the month.
Japan Times
COMMENTARY / World
May 17, 2023
A breakthrough on Alzheimer's is closer than ever
Promising data could open the door to insurance coverage for expensive new Alzheimer's drugs, bringing them closer to patients.
Japan Times
WORLD / Science & Health / FOCUS
May 9, 2023
Drugs developed to treat diabetes may offer new approach against Alzheimer's
Experts hope that by improving glucose metabolism, and tamping down inflammation in the entire body, they can slow progression of diseases like Alzheimer's and Parkinson's.
Japan Times
WORLD / Science & Health
May 5, 2023
Experimental Alzheimer's drug slowed disease by 35% in trial, Eli Lilly reports
The results provide what experts say is the strongest evidence yet that removing sticky amyloid plaques from the brain benefits patients with the fatal disease.
Japan Times
JAPAN
Jan 30, 2023
Priority review status given to Alzheimer's drug developed by Eisai and Biogen
The companies said priority review in Japan is granted to new medicines recognized as having high medical utility for serious diseases.
Japan Times
BUSINESS
Jan 16, 2023
Eisai and Biogen apply for approval of Alzheimer's drug in Japan
The two companies hope to gain approval by the end of the year following the U.S. Food and Drug Administration's decision earlier in the month to grant it fast-track approval.
Japan Times
BUSINESS / Markets
Jan 10, 2023
Eisai shares jump after FDA approves Alzheimer’s drug lecanemab
The drug, to be sold under the brand name Leqembi, was approved by the Food and Drug Administration under an accelerated pathway.
No link to Nankai Trough quake seen after temblor in Shikoku
Satoshi Harada from the Meteorological Agency explains about the magnitude 6.6 earthquake during a news conference early Thursday.
Tehran signals no retaliation against Israel after drones attack Iran
A reported strike against Iran by Israel on Friday came against the backdrop of Iran's support for the Palestinian Hamas militant group, whose assault into Israel on Oct. 7 triggered Israel's invasion of Gaza.
In a first, Japan doctors sue Google over negative reviews on firm's map app
One of the lawyers representing a group of doctors suing Google told a news conference that the main purpose of the lawsuit is not to seek compensation but instead to raise awareness over various problems with the Google Maps system.
Japanese acts seize Coachella's spotlight — and this ain't your typical J-pop
Four-piece Atarashii Gakko! and Okinawan rapper Awich (center) shared the Mojave Stage at 88Risings’s “Futures” showcase at Coachella Valley Music and Arts Festival last weekend.
Former No. 1 Kento Momota retires from international badminton at 29
Badminton star Kento Momota leaves a news conference after announcing his retirement from Japan's national team, in Tokyo on Thursday.
'House of the Owl' brings Hollywood values to Japanese TV
In the new Disney+ series “House of the Owl,” Min Tanaka (left) plays a powerful political fixer, or “kuromaku,” who has a troubled relationship with his adult children, particularly his idealistic son, played by Mackenyu.
Benefits and risks: AUKUS looks to take gamble on Japan
U.S. President Joe Biden, Australian Prime Minister Anthony Albanese and British leader Rishi Sunak deliver remarks on the AUKUS partnership, after a trilateral meeting, at Naval Base Point Loma in San Diego in March last year.
Baseball Hall of Fame to highlight history of Japan-U.S. ties in new exhibit
Josh Rawitch, president of the National Baseball Hall of Fame, holds a baseball thrown by former Dodgers pitcher Hideo Nomo during a no-hitter in 1996 while seated next to a Dodgers uniform used by Shohei Ohtani this season during a news conference at the U.S. ambassador's residence in Tokyo
Latest Biden chip deal highlights U.S. semiconductor successes
U.S. President Joe Biden speaks as he announces a preliminary agreement with Intel for a major CHIPS and Science Act award, during a visit to the Intel Ocotillo Campus in Chandler, Arizona, on March 20.
Kyoto’s demon night parade lives to haunt another day
In a Kyoto long past, the "hyakki yagyō" (100 demon night parade) haunted a sleepy corner of Kyoto. Now, one enterprising monster enthusiast has won a small batttle to keep the march alive.

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Historically, kabuki was considered the entertainment of the merchant and peasant classes, a far cry from how it is regarded today.
For Japan's oldest kabuki theater, the show must go on
By Lance Henderstein

SUSTAINABLE JAPAN

Vol. 34: Tokyo, a vanguard city for sustainability
Vol. 34: Tokyo, a vanguard city for sustainability

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER